|
|
||||||||||||||||||||||||||||||||||
© 2007 The American Thoracic Society doi: 10.1513/pats.200608-156JG A Proteomic Primer for the ClinicianDepartments of Medicine, Biological Chemistry, and Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland Correspondence and requests for reprints should be addressed to Yurong Guo, Ph.D., Johns Hopkins University Bayview Campus, 5200 Eastern Avenue, Mason F. Lord Building, Center tower, Room 609, Baltimore, MD 21224. E-mail: yguo7{at}jhmi.edu ABSTRACT Proteomics is a rapidly developing field and it opens new horizons in many research areas of life sciences. In the field of medicine, proteomics promises to accelerate the discovery of new drug targets and protein disease markers useful for in vitro diagnosis. In this article, we review the current proteomics technologies for biomarker discovery and validation, which include two-dimensional gel electrophoresis, one- and two-dimensional liquid chromatography, and proteomic microarrays. We will also review proteomic strategies for proteinprotein interactions and identification of post-translational modifications. Selection of the more effective technology or combination of technologies is required to maximize the interpretation and utility of the data.
Key Words: 2D electrophoresis multiple dimensional chromatography post-translational modification proteomic microarrays proteomics This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||